What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Immunology, Internal medicine, Virology, Viral load and Acquired immunodeficiency syndrome are his primary areas of study.
His research brings together the fields of Cerebrospinal fluid and Immunology.
His Internal medicine study incorporates themes from Sida, Surgery and Pharmacology.
His Virology research includes themes of Chemokine, Peripheral blood mononuclear cell, Antibody and Antigen.
His Viral load study integrates concerns from other disciplines, such as Raltegravir Potassium, Tolerability, Randomized controlled trial, Reverse-transcriptase inhibitor and Raltegravir.
The study incorporates disciplines such as Seroconversion, Incidence and Risk factor in addition to Acquired immunodeficiency syndrome.
His most cited work include:
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. (1123 citations)
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection (610 citations)
- Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. (557 citations)
What are the main themes of his work throughout his whole career to date?
Adriano Lazzarin spends much of his time researching Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Viral load.
His study in Viral disease, Virus, Immunopathology, Immune system and Antibody are all subfields of Immunology.
His Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Ritonavir.
His Virology study combines topics from a wide range of disciplines, such as Peripheral blood mononuclear cell and Genotype.
His studies in Acquired immunodeficiency syndrome integrate themes in fields like Epidemiology, Incidence, Pediatrics and Seroconversion.
Adriano Lazzarin usually deals with Regimen and limits it to topics linked to Pharmacology and Efavirenz.
He most often published in these fields:
- Immunology (40.77%)
- Internal medicine (39.41%)
- Virology (34.57%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (39.41%)
- Virology (34.57%)
- Gastroenterology (15.12%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Virology, Gastroenterology, Viral load and Regimen.
The various areas that Adriano Lazzarin examines in his Internal medicine study include Emtricitabine, Pharmacology and Ritonavir.
His research in Virology intersects with topics in Immunology, Genotype and Antiretroviral therapy.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Rilpivirine, Hepatitis C, Retrospective cohort study, Confidence interval and Lamivudine.
His Viral load research integrates issues from Viremia and Surgery.
Adriano Lazzarin has included themes like Tenofovir alafenamide, Protease inhibitor, Randomized controlled trial and Cohort in his Regimen study.
Between 2011 and 2021, his most popular works were:
- Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study (208 citations)
- Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study (116 citations)
- Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial (115 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Adriano Lazzarin focuses on Internal medicine, Viral load, Virology, Gastroenterology and Regimen.
His Internal medicine research incorporates themes from Efavirenz, Pharmacology and Emtricitabine.
His Viral load research includes elements of Interquartile range, Cross-sectional study, Viremia, Retrospective cohort study and Antiretroviral therapy.
His work deals with themes such as RNA, Raltegravir, Immunology and Genotype, which intersect with Virology.
The concepts of his Gastroenterology study are interwoven with issues in Liver biopsy, Hepatitis C virus, Hepatitis C, Ritonavir and Coinfection.
His studies deal with areas such as Tenofovir alafenamide, Discontinuation and Pediatrics as well as Regimen.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
